<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">J Anaesthesiol Clin Pharmacol</journal-id><journal-id journal-id-type="iso-abbrev">J Anaesthesiol Clin Pharmacol</journal-id><journal-id journal-id-type="publisher-id">JOACP</journal-id><journal-title-group><journal-title>Journal of Anaesthesiology, Clinical Pharmacology</journal-title></journal-title-group><issn pub-type="ppub">0970-9185</issn><issn pub-type="epub">2231-2730</issn><publisher><publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22557741</article-id><article-id pub-id-type="pmc">3339723</article-id><article-id pub-id-type="publisher-id">JOACP-28-190</article-id><article-id pub-id-type="doi">10.4103/0970-9185.94840</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Role of very short-term intravenous hydrocortisone in reducing postdural puncture headache</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Alam</surname><given-names>Md Rabiul</given-names></name><xref ref-type="aff" rid="aff1"></xref><xref ref-type="corresp" rid="cor1"></xref></contrib><contrib contrib-type="author"><name><surname>Rahman</surname><given-names>Md Aminur</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Ershad</surname><given-names>Reza</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib></contrib-group><aff id="aff1">Department of Anaesthesia and Intensive Care, Combined Military Hospital, Chittagong, Bangladesh</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Lt Col Md Rabiul Alam, Department of Anaesthesia and Intensive Care, Combined Military Hospital, Chittagong, Bangladesh. E-mail: <email xlink:href="rabiuldr@gmail.com">rabiuldr@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Apr-Jun</season><year>2012</year></pub-date><volume>28</volume><issue>2</issue><fpage>190</fpage><lpage>193</lpage><permissions><copyright-statement>Copyright: © Journal of Anaesthesiology Clinical Pharmacology</copyright-statement><copyright-year>2012</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title><offsets xml_i="2918" xml_f="2928" txt_i="11" txt_f="21">Objective:</offsets></title><p><offsets xml_i="2939" xml_f="3135" txt_i="22" txt_f="218">Headache is not an uncommon complication of spinal anesthesia. The efficacy of intravenous (IV) hydrocortisone in treating the patients with postdural puncture headache was observed in this study.</offsets></p></sec><sec id="st2"><title><offsets xml_i="3166" xml_f="3188" txt_i="220" txt_f="242">Materials and Methods:</offsets></title><p><offsets xml_i="3199" xml_f="3682" txt_i="243" txt_f="726">Sixty patients with headache following spinal anesthesia were randomly allocated into two groups. Thirty patients received only conventional therapy (recumbent positioning, IV or oral hydration, analgesics with caffeine, stool softeners, and soft diet) plus 2 ml of normal saline IV (placebo) 8 hourly for 48 h. Thirty other patients received conventional therapy plus hydrocortisone IV (100 mg in 2 ml 8 hourly for 48 h). Headache intensity was measured using visual analogue scale.</offsets></p></sec><sec id="st3"><title><offsets xml_i="3713" xml_f="3721" txt_i="728" txt_f="736">Results:</offsets></title><p><offsets xml_i="3732" xml_f="3826" txt_i="737" txt_f="831">No significant difference was observed in baseline headache intensity between the two groups (</offsets><italic><offsets xml_i="3834" xml_f="3835" txt_i="831" txt_f="832">P</offsets></italic><offsets xml_i="3844" xml_f="4063" txt_i="832" txt_f="1051"> = 0.6642) before beginning of treatment. After 6 h, the mean headache intensity in patients treated conventionally was 6.02 ± 2.46, while it was 2.06 ± 1.98 in other patients who received additional hydrocortisone IV (</offsets><italic><offsets xml_i="4071" xml_f="4072" txt_i="1051" txt_f="1052">P</offsets></italic><offsets xml_i="4081" xml_f="4219" txt_i="1052" txt_f="1187"> &lt; 0.0001). After 24 h, headache intensity was 3.77 ± 1.85 in conventionally treated group versus 0.94 ± 2.67 in hydrocortisone group (</offsets><italic><offsets xml_i="4227" xml_f="4228" txt_i="1187" txt_f="1188">P</offsets></italic><offsets xml_i="4237" xml_f="4353" txt_i="1188" txt_f="1301"> &lt; 0.0001), while it was 1.95 ± 1.12 in conventionally treated group versus 0.69 ± 1.64 in hydrocortisone group (</offsets><italic><offsets xml_i="4361" xml_f="4362" txt_i="1301" txt_f="1302">P</offsets></italic><offsets xml_i="4371" xml_f="4392" txt_i="1302" txt_f="1323"> = 0.001) after 48 h.</offsets></p></sec><sec id="st4"><title><offsets xml_i="4423" xml_f="4435" txt_i="1325" txt_f="1337">Conclusions:</offsets></title><p><offsets xml_i="4446" xml_f="4745" txt_i="1338" txt_f="1637">Very short-term use of IV hydrocortisone was found effective in reducing headache following spinal anesthesia. However, its clear mechanism of action is yet to be determined. Large-scale studies are recommended to consider the steroid therapy as a standard treatment for postdural puncture headache.</offsets></p></sec></abstract><kwd-group><kwd>Corticosteroids</kwd><kwd>headache</kwd><kwd>hydrocortisone</kwd><kwd>postdural puncture headache</kwd><kwd>spinal anesthesia</kwd></kwd-group></article-meta></front><body><sec id="sec1-1"><title><offsets xml_i="4978" xml_f="4990" txt_i="1646" txt_f="1658">Introduction</offsets></title><p><offsets xml_i="5001" xml_f="5841" txt_i="1659" txt_f="2499">Postdural puncture headache (PDPH) is not an uncommon following subarachnoid block (SAB) and accidental dural puncture (ADP) during attempting epidural anesthesia. PDPH might also occur following lumbar puncture and myelography. This headache is usually a severe, dull, nonthrobbing pain, often fronto-occipital, which is aggravated in upright and diminished in supine position. It may be accompanied by nausea, vomiting, or visual disturbances. Headache begins 1 or 2 days after spinal anesthesia and if left untreated, usually relieves spontaneously within a week, but the patients suffer miserably during this period. In case headache is severe, other causes of headache must be looked for such as migraine, hypertension, meningitis, cortical vein thrombosis, pneumocephalus, sinusitis, nonspecific headache, and intracranial pathology.[</offsets><xref ref-type="bibr" rid="ref1"><offsets xml_i="5874" xml_f="5875" txt_i="2499" txt_f="2500">1</offsets></xref><offsets xml_i="5882" xml_f="5883" txt_i="2500" txt_f="2501">]</offsets></p><p><offsets xml_i="5890" xml_f="6292" txt_i="2502" txt_f="2904">Cerebrospinal fluid (CSF) leakage following dural puncture is the most accepted mechanism of this headache. Reduction in CSF pressure lessens the cushioning effect of brain, allowing it to sag within the intracranial vault, and stimulates dural pain receptors especially in upright position. Headache continues until dural hole repairs and it is relieved when CSF volume and pressure return to normal.[</offsets><xref ref-type="bibr" rid="ref2"><offsets xml_i="6325" xml_f="6326" txt_i="2904" txt_f="2905">2</offsets></xref><offsets xml_i="6333" xml_f="6334" txt_i="2905" txt_f="2906">]</offsets></p><p><offsets xml_i="6341" xml_f="6760" txt_i="2907" txt_f="3326">Current conventional and symptomatic treatments for PDPH include bed rest, hydration, analgesics, caffeine, sumatriptan, aminophyline, and ACTH. But none of these therapeutic approaches can relieve this headache completely and just help the patients to endure it. An epidural blood patch (EBP) is performed if the headache is too severe to limit one's activity or if any evidence of cranial nerve involvement is noted.[</offsets><xref ref-type="bibr" rid="ref3"><offsets xml_i="6793" xml_f="6794" txt_i="3326" txt_f="3327">3</offsets></xref><offsets xml_i="6801" xml_f="6802" txt_i="3327" txt_f="3328">]</offsets></p><p><offsets xml_i="6809" xml_f="6889" txt_i="3329" txt_f="3409">The role of corticosteroids in management of postoperative pain and cancer pain[</offsets><xref ref-type="bibr" rid="ref4"><offsets xml_i="6922" xml_f="6923" txt_i="3409" txt_f="3410">4</offsets></xref><offsets xml_i="6930" xml_f="7021" txt_i="3410" txt_f="3501">] has been discussed in the recent years. Some authors have used these drugs to treat PDPH[</offsets><xref ref-type="bibr" rid="ref5"><offsets xml_i="7054" xml_f="7055" txt_i="3501" txt_f="3502">5</offsets></xref><offsets xml_i="7062" xml_f="7118" txt_i="3502" txt_f="3558">] and syndrome of spontaneous intracranial hypotension.[</offsets><xref ref-type="bibr" rid="ref6"><offsets xml_i="7151" xml_f="7152" txt_i="3558" txt_f="3559">6</offsets></xref><offsets xml_i="7159" xml_f="7367" txt_i="3559" txt_f="3767">] There is limited literature on the role of steroids in PDPH. The present study was designed to observe the efficacy of intravenous (IV) hydrocortisone in reducing headache intensity after spinal anesthesia.</offsets></p></sec><sec sec-type="materials|methods" id="sec1-2"><title><offsets xml_i="7430" xml_f="7451" txt_i="3769" txt_f="3790">Materials and Methods</offsets></title><p><offsets xml_i="7462" xml_f="7936" txt_i="3791" txt_f="4265">Sixty adult patients (ASA I and II) who developed PDPH after nonobstetric surgery were observed between July 2010 and June 2011. A prior approval was obtained from the ethical committee of the hospital. Patients with history of cluster headache, convulsion, cerebrovascular accident, preeclampsia, eclampsia, coagulopathy, or previous neurological diseases were excluded. The modus of treatment was thoroughly explained to selected patients and informed consents were taken.</offsets></p><p><offsets xml_i="7943" xml_f="8615" txt_i="4266" txt_f="4938">All SABs were performed by anesthesiologists not involved in this study. The procedures were done in sitting position through midline approach with 25-gauge Quincke needle and 0.5% bupivacaine heavy. Patients with PDPH were allocated in two groups by computer generated randomization: 30 patients were treated conventionally: Recumbent positioning, IV or oral hydration, analgesics with caffeine, stool softeners, and soft diet plus 2 ml of normal saline IV (placebo) 8 hourly for 48 h. Other 30 patients were treated conventionally and received 100 mg hydrocortisone, diluted in 2 ml, IV 8 hourly for 48 h. The patients and the single observer were blinded to this study.</offsets></p><p><offsets xml_i="8622" xml_f="9120" txt_i="4939" txt_f="5437">The mean of headache intensity was measured in all 60 patients after 1 min in upright position. A trained observer asked the patients about severity of headache at 0, 6, 24, and 48 h after beginning of treatment. Using a 10 cm visual analogue scale (VAS), the intensity of headache (0–1, no headache; 2–4, mild headache; 5–7, moderate headache; and 8–10, severe headache) were recorded at 6, 24, and 48 h after commencement of treatment in two groups. Statistical analysis was done using Student's </offsets><italic><offsets xml_i="9128" xml_f="9129" txt_i="5437" txt_f="5438">t</offsets></italic><offsets xml_i="9138" xml_f="9221" txt_i="5438" txt_f="5521">-test to compare the mean (±SD) of headache intensities between the two groups and </offsets><italic><offsets xml_i="9229" xml_f="9230" txt_i="5521" txt_f="5522">P</offsets></italic><offsets xml_i="9239" xml_f="9283" txt_i="5522" txt_f="5563"> value &lt; 0.05 was considered significant.</offsets></p></sec><sec sec-type="results" id="sec1-3"><title><offsets xml_i="9336" xml_f="9343" txt_i="5565" txt_f="5572">Results</offsets></title><p><offsets xml_i="9354" xml_f="9505" txt_i="5573" txt_f="5724">Before beginning of treatment all 60 patients had severe headache. The demographic characteristics including age, sex, height, and weight are shown in </offsets><xref ref-type="table" rid="T1"><offsets xml_i="9537" xml_f="9544" txt_i="5724" txt_f="5731">Table 1</offsets></xref><offsets xml_i="9551" xml_f="9821" txt_i="5731" txt_f="6001">. The mean (±SD) baseline intensity of headache was 9.17 ± 1.69 in the conventionally treated group and 9.32 ± 0.83 in hydrocortisone group as per VAS. The headache intensities (mean ± SD) at 6, 24, and 48 h after commencement of treatment in two groups were tabulated [</offsets><xref ref-type="table" rid="T2"><offsets xml_i="9853" xml_f="9860" txt_i="6001" txt_f="6008">Table 2</offsets></xref><offsets xml_i="9867" xml_f="9923" txt_i="6008" txt_f="6064">] and the means of headache intensities were plotted in </offsets><xref ref-type="fig" rid="F1"><offsets xml_i="9953" xml_f="9961" txt_i="6064" txt_f="6072">Figure 1</offsets></xref><offsets xml_i="9968" xml_f="9969" txt_i="6072" txt_f="6073">.</offsets></p><table-wrap id="T1" position="float"><label><offsets xml_i="10017" xml_f="10024" txt_i="6074" txt_f="6081">Table 1</offsets></label><caption><p><offsets xml_i="10044" xml_f="10071" txt_i="6081" txt_f="6108">Demographic characteristics</offsets></p></caption><graphic xlink:href="JOACP-28-190-g001"></graphic></table-wrap><table-wrap id="T2" position="float"><label><offsets xml_i="10192" xml_f="10199" txt_i="6109" txt_f="6116">Table 2</offsets></label><caption><p><offsets xml_i="10219" xml_f="10381" txt_i="6116" txt_f="6278">Headache intensities (mean ± SD) following the beginning of treatment in the conventionally treated and conventional treatment + intravenous hydrocortisone groups</offsets></p></caption><graphic xlink:href="JOACP-28-190-g002"></graphic></table-wrap><fig id="F1" position="float"><label><offsets xml_i="10495" xml_f="10503" txt_i="6279" txt_f="6287">Figure 1</offsets></label><caption><p><offsets xml_i="10523" xml_f="10589" txt_i="6287" txt_f="6353">Comparison of headache during to 48 h after beginning of treatment</offsets></p></caption><graphic xlink:href="JOACP-28-190-g003"></graphic></fig><p><offsets xml_i="10662" xml_f="11047" txt_i="6354" txt_f="6739">Eleven (11/30, 36.66%) patients in conventional treatment plus IV hydrocortisone group required three doses of hydrocortisone to get complete relief of symptoms. But one patient with severe headache from each group required EBP whose symptoms were not resolved even after 3 days therapy. No adverse effects were noted and no patient was re-referred to hospital for relapse of headache.</offsets></p></sec><sec sec-type="discussion" id="sec1-4"><title><offsets xml_i="11103" xml_f="11113" txt_i="6741" txt_f="6751">Discussion</offsets></title><p><offsets xml_i="11124" xml_f="11131" txt_i="6752" txt_f="6759">Toriel </offsets><italic><offsets xml_i="11139" xml_f="11144" txt_i="6759" txt_f="6764">et al</offsets></italic><offsets xml_i="11153" xml_f="11227" txt_i="6764" txt_f="6838">. proposed the use of IV hydrocortisone in the treatment of PDPH in 2002.[</offsets><xref ref-type="bibr" rid="ref7"><offsets xml_i="11260" xml_f="11261" txt_i="6838" txt_f="6839">7</offsets></xref><offsets xml_i="11268" xml_f="11476" txt_i="6839" txt_f="7047">] In patients with severe PDPH after cesarean section received 100 mg hydrocortisone IV 8 hourly for 3 days, in addition to the conventional therapy, headache disappeared completely 12 h after the last dose.[</offsets><xref ref-type="bibr" rid="ref8"><offsets xml_i="11509" xml_f="11510" txt_i="7047" txt_f="7048">8</offsets></xref><offsets xml_i="11517" xml_f="11607" txt_i="7048" txt_f="7138">] The technique of anesthesia and needle gauge was not the same in these patients. Ashraf </offsets><italic><offsets xml_i="11615" xml_f="11620" txt_i="7138" txt_f="7143">et al</offsets></italic><offsets xml_i="11629" xml_f="11696" txt_i="7143" txt_f="7210">. studied patients with PDPH following cesarean section under SAB.[</offsets><xref ref-type="bibr" rid="ref9"><offsets xml_i="11729" xml_f="11730" txt_i="7210" txt_f="7211">9</offsets></xref><offsets xml_i="11737" xml_f="12004" txt_i="7211" txt_f="7478">] We administered hydrocortisone to the patients with PDPH who underwent various types of surgery under SAB, using the same needle gauge for all patients. Addition of hydrocortisone IV with conventional treatment for patients with PDPH reduced headache significantly.</offsets></p><p><offsets xml_i="12011" xml_f="12124" txt_i="7479" txt_f="7592">Efficacy of corticosteroids to treat the syndrome of spontaneous intracranial hypotension has been demonstrated.[</offsets><xref ref-type="bibr" rid="ref10"><offsets xml_i="12158" xml_f="12160" txt_i="7592" txt_f="7594">10</offsets></xref><offsets xml_i="12167" xml_f="12534" txt_i="7594" txt_f="7961">] The syndrome is characterized by low CSF pressure, usually severe fronto-occipital headache which is aggravated in upright position and not relieved by analgesics. The quality of headache and response to therapy is very similar to PDPH. Headache of patients with spontaneous intracranial hypotension disappeared in 2–4 weeks after treatment with oral prednisolone.[</offsets><xref ref-type="bibr" rid="ref11"><offsets xml_i="12568" xml_f="12570" txt_i="7961" txt_f="7963">11</offsets></xref><offsets xml_i="12577" xml_f="12632" txt_i="7963" txt_f="8018">] Other researchers have reported the similar results.[</offsets><xref ref-type="bibr" rid="ref12"><offsets xml_i="12666" xml_f="12668" txt_i="8018" txt_f="8020">12</offsets></xref><offsets xml_i="12675" xml_f="12676" txt_i="8020" txt_f="8021">]</offsets></p><p><offsets xml_i="12683" xml_f="13109" txt_i="8022" txt_f="8448">The mechanism by which corticosteroids resolve PDPH and headache of intracranial hypotension has not been elucidated. Patients with headache associated with spontaneous low CSF pressure, present a variable amount of CSF in the spinal extradural space with associated dilated epidural veins in the high cervical portion. CSF hypovolemia, and not the intracranial hypotension, may be the pathogenetic mechanism of this symptom.[</offsets><xref ref-type="bibr" rid="ref13"><offsets xml_i="13143" xml_f="13145" txt_i="8448" txt_f="8450">13</offsets></xref><offsets xml_i="13152" xml_f="13288" txt_i="8450" txt_f="8586">] Steroids may exert their clinical effects by favoring the reabsorption of CSF from the extradural space and thus increase CSF volume.[</offsets><xref ref-type="bibr" rid="ref14"><offsets xml_i="13322" xml_f="13324" txt_i="8586" txt_f="8588">14</offsets></xref><offsets xml_i="13331" xml_f="13501" txt_i="8588" txt_f="8758">] Steroids suppress arachidonic acid production through lipocortin-induced phospholipase inhibition, which ultimately inhibits production of algogenic prostaglandins (PGE</offsets><sub><offsets xml_i="13506" xml_f="13507" txt_i="8758" txt_f="8759">2</offsets></sub><offsets xml_i="13513" xml_f="13521" txt_i="8759" txt_f="8767"> and PGI</offsets><sub><offsets xml_i="13526" xml_f="13527" txt_i="8767" txt_f="8768">2</offsets></sub><offsets xml_i="13533" xml_f="13557" txt_i="8768" txt_f="8792">) and leukotrienes (LT-B</offsets><sub><offsets xml_i="13562" xml_f="13563" txt_i="8792" txt_f="8793">4</offsets></sub><offsets xml_i="13569" xml_f="13572" txt_i="8793" txt_f="8796">).[</offsets><xref ref-type="bibr" rid="ref15"><offsets xml_i="13606" xml_f="13608" txt_i="8796" txt_f="8798">15</offsets></xref><offsets xml_i="13615" xml_f="13710" txt_i="8798" txt_f="8893">] Corticosteroids block production of proinflammatory cytokines such as IL-1, IL-2, and TNF-α.[</offsets><xref ref-type="bibr" rid="ref16"><offsets xml_i="13744" xml_f="13746" txt_i="8893" txt_f="8895">16</offsets></xref><offsets xml_i="13753" xml_f="14133" txt_i="8895" txt_f="9275">] It seems that analgesic action of steroids in PDPH may relate to their anti-inflammatory effects at dural puncture site. During the healing process of dural puncture site, inflammatory mediators those are secreted from immune cells, spread in CSF, stimulate pain receptors, and cause headache. Steroids may suppress production of these algogenic mediators and relieve headache.[</offsets><xref ref-type="bibr" rid="ref15"><offsets xml_i="14167" xml_f="14169" txt_i="9275" txt_f="9277">15</offsets></xref><offsets xml_i="14176" xml_f="14282" txt_i="9277" txt_f="9383">] Since this very short-term use of steroids may have only hypersensitivity reaction like all other drugs[</offsets><xref ref-type="bibr" rid="ref17"><offsets xml_i="14316" xml_f="14318" txt_i="9383" txt_f="9385">17</offsets></xref><offsets xml_i="14325" xml_f="14362" txt_i="9385" txt_f="9422">] and no persisting adverse effects,[</offsets><xref ref-type="bibr" rid="ref18"><offsets xml_i="14396" xml_f="14398" txt_i="9422" txt_f="9424">18</offsets></xref><offsets xml_i="14405" xml_f="14448" txt_i="9424" txt_f="9467">] its administration can be adopted safely.</offsets></p><p><offsets xml_i="14455" xml_f="14809" txt_i="9468" txt_f="9822">Quinke needles were used in the subjects of this study (they are mostly used in our country). It was preferred to observe the outcome of PDPH in the prevailing perspective. A limitation of this study was that we did not consider the relation between body mass index and headache and that a wide interpersonal variation in presentations of PDPH was noted.</offsets></p></sec><sec sec-type="conclusion" id="sec1-5"><title><offsets xml_i="14865" xml_f="14875" txt_i="9824" txt_f="9834">Conclusion</offsets></title><p><offsets xml_i="14886" xml_f="15105" txt_i="9835" txt_f="10054">The efficacy of IV hydrocortisone in reducing the headache following dural puncture has been demonstrated in this study. Large-scale studies are recommended to establish steroid therapy as a standard treatment for PDPH.</offsets></p></sec></body><back><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rabiul</surname><given-names>MA</given-names></name><name><surname>Raheen</surname><given-names>MR</given-names></name><name><surname>Iqbal</surname><given-names>KM</given-names></name><name><surname>Chowdhury</surname><given-names>RA</given-names></name></person-group><article-title>Headache following Spinal Anaesthesia: A Review on Recent Update</article-title><source>J Bangladesh Coll Phys Surg</source><year>2011</year><volume>29</volume><fpage>32</fpage><lpage>40</lpage></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munnur</surname><given-names>U</given-names></name><name><surname>Suresh</surname><given-names>MS</given-names></name></person-group><article-title>Backache, headache, and neurologic deficit after regional anesthesia</article-title><source>Anesthesiol Clin North America</source><year>2003</year><volume>21</volume><fpage>71</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">12698833</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turnbull</surname><given-names>DK</given-names></name><name><surname>Shepherd</surname><given-names>DB</given-names></name></person-group><article-title>Post-dural puncture headache: Pathogenesis, prevention and treatment</article-title><source>Br J Anaesth</source><year>2003</year><volume>91</volume><fpage>718</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">14570796</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vyvey</surname><given-names>M</given-names></name></person-group><article-title>Steroids as pain relief adjuvants</article-title><source>Can Fam Physician</source><year>2010</year><volume>56</volume><fpage>1295</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">21156893</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chohan</surname><given-names>U</given-names></name><name><surname>Hamdani</surname><given-names>GA</given-names></name></person-group><article-title>Post Dural Puncture Headache</article-title><source>J Pak Med Assoc</source><year>2003</year><volume>53</volume><fpage>246</fpage><lpage>55</lpage></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gentile</surname><given-names>S</given-names></name><name><surname>Giudice</surname><given-names>RL</given-names></name><name><surname>Martino</surname><given-names>PD</given-names></name><name><surname>Rainero</surname><given-names>I</given-names></name><name><surname>Pinessi</surname><given-names>L</given-names></name></person-group><article-title>Headache attributed to spontaneous low CSF pressure: report of three cases responsive to corticosteroids</article-title><source>Eur J Neurol</source><year>2004</year><volume>11</volume><fpage>849</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">15667418</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turiel</surname><given-names>M</given-names></name><name><surname>Simón</surname><given-names>MO</given-names></name><name><surname>Lastra</surname><given-names>J</given-names></name><name><surname>Pascual</surname><given-names>JA</given-names></name></person-group><article-title>Treatment of post-dural-puncture headache with intravenous cortisone</article-title><source>Rev Esp Anestesiol Reanim</source><year>2002</year><volume>49</volume><fpage>101</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">12025238</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neves</surname><given-names>JF</given-names></name><name><surname>Vieira</surname><given-names>VL</given-names></name><name><surname>Saldanha</surname><given-names>RM</given-names></name><name><surname>Fde</surname><given-names>A</given-names></name><name><surname>Neto</surname><given-names>M</given-names></name><name><surname>Magalhães</surname><given-names>MG</given-names></name><name><surname>Neves</surname><given-names>MM</given-names></name><name><surname>Araújo</surname><given-names>FP</given-names></name></person-group><article-title>Hydrocortisone treatment and prevent post-dural puncture headache: Case reports</article-title><source>Rev Bras Anestesiol</source><year>2005</year><volume>55</volume><fpage>343</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">19471839</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashraf</surname><given-names>MA</given-names></name><name><surname>Sadeghi</surname><given-names>A</given-names></name><name><surname>Azarbakht</surname><given-names>Z</given-names></name><name><surname>Salehi</surname><given-names>S</given-names></name><name><surname>Hamediseresht</surname><given-names>E</given-names></name></person-group><article-title>Hydrocortisone in post-dural puncture headache</article-title><source>ME J Anesth</source><year>2007</year><volume>19</volume><fpage>415</fpage><lpage>22</lpage></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>M</given-names></name><name><surname>Shah</surname><given-names>GV</given-names></name><name><surname>Adams</surname><given-names>KM</given-names></name><name><surname>Turner</surname><given-names>RS</given-names></name><name><surname>Foster</surname><given-names>NL</given-names></name></person-group><article-title>Spontaneous intracranial hypotension causing reversible fronto-temporal dementia</article-title><source>Neurology</source><year>2002</year><volume>58</volume><fpage>1285</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11971102</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silberstein</surname><given-names>SD</given-names></name></person-group><article-title>Syndrome of spontaneous intracranial hypotension</article-title><source>Cephalalgia</source><year>1999</year><volume>19</volume><fpage>73</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">10214529</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pascual</surname><given-names>LF</given-names></name><name><surname>Santos</surname><given-names>S</given-names></name><name><surname>Escalza</surname><given-names>I</given-names></name><name><surname>Iñiguez</surname><given-names>C</given-names></name><name><surname>Morales-Asín</surname><given-names>F</given-names></name></person-group><article-title>Spontaneous intracranial hypotension: Quick clinical and magnetic resonance imaging response to corticosteroids.A case report</article-title><source>Headache</source><year>2002</year><volume>42</volume><fpage>359</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">12047337</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>David</surname><given-names>B</given-names></name><name><surname>Richard</surname><given-names>B</given-names></name><name><surname>Lipton</surname></name><name><surname>Sait</surname><given-names>A</given-names></name></person-group><article-title>Post-Dural Puncture Headache: Diagnosis, Epidemiology, Etiology, and Pathophysiology</article-title><source>Headache</source><year>2010</year><volume>50</volume><fpage>1144</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">20533959</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyazawa</surname><given-names>K</given-names></name><name><surname>Shiga</surname><given-names>Y</given-names></name><name><surname>Hasegawa</surname><given-names>T</given-names></name><name><surname>Endoh</surname><given-names>M</given-names></name><name><surname>Okita</surname><given-names>N</given-names></name><name><surname>Higano</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>CSF hypovolemia vs.intracranial hypotension in “spontaneous intracranial hypotension syndrome”</article-title><source>Neurology</source><year>2003</year><volume>60</volume><fpage>941</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12654957</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilron</surname><given-names>I</given-names></name></person-group><article-title>Corticosteroids in postoperative pain management: Future research directions for a multifaceted therapy</article-title><source>Acta Anaesthesiol Scand</source><year>2004</year><volume>48</volume><fpage>1221</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">15504179</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elenkov</surname><given-names>IJ</given-names></name><name><surname>Chrousos</surname><given-names>GP</given-names></name></person-group><article-title>Stress Hormones, Pro-inflammatory and Anti-inflammatory Cytokines, and Autoimmunity</article-title><source>Ann N Y Acad Sci</source><year>2002</year><volume>966</volume><fpage>290</fpage><lpage>303</lpage><pub-id pub-id-type="pmid">12114286</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graeme</surname><given-names>PC</given-names></name><name><surname>Paterson</surname><given-names>E</given-names></name><name><surname>Keenan</surname><given-names>F</given-names></name></person-group><article-title>An unexpected response to intravenous hydrocortisone succinate in an asthmatic patient</article-title><source>Br J Clin Pharmacol</source><year>2005</year><volume>60</volume><fpage>342</fpage><pub-id pub-id-type="pmid">16120076</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitra</surname><given-names>R</given-names></name><name><surname>Jones</surname><given-names>S</given-names></name></person-group><article-title>Adjuvant Analgesics in Cancer Pain: A Review</article-title><source>Am J Hosp Palliat Care</source><year>2012</year><volume>29</volume><fpage>70</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">21712306</pub-id></element-citation></ref></ref-list></back></article>